KEGG   PATHWAY: esp04520
Entry
esp04520                    Pathway                                
Name
Adherens junction - Etheostoma spectabile (orangethroat darter)
Description
Cell-cell adherens junctions (AJs), the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. At AJs, E-cadherin serves as an essential cell adhesion molecules (CAMs). The cytoplasmic tail binds beta-catenin, which in turn binds alpha-catenin. Alpha-catenin is associated with F-actin bundles directly and indirectly. The integrity of the cadherin-catenin complex is negatively regulated by phosphorylation of beta-catenin by receptor tyrosine kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which leads to dissociation of the cadherin-catenin complex. Integrity of this complex is positively regulated by beta -catenin phosphorylation by casein kinase II, and dephosphorylation by protein tyrosine phosphatases. Changes in the phosphorylation state of beta-catenin affect cell-cell adhesion, cell migration and the level of signaling beta-catenin. Wnt signaling acts as a positive regulator of beta-catenin by inhibiting beta-catenin degradation, which stabilizes beta-catenin, and causes its accumulation. Cadherin may acts as a negative regulator of signaling beta-catenin as it binds beta-catenin at the cell surface and thereby sequesters it from the nucleus. Nectins also function as CAMs at AJs, but are more highly concentrated at AJs than E-cadherin. Nectins transduce signals through Cdc42 and Rac, which reorganize the actin cytoskeleton, regulate the formation of AJs, and strengthen cell-cell adhesion.
Class
Cellular Processes; Cellular community - eukaryotes
Pathway map
esp04520  Adherens junction
esp04520

Other DBs
GO: 0005912
Organism
Etheostoma spectabile (orangethroat darter) [GN:esp]
Gene
116669655  [KO:K05703] [EC:2.7.10.2]
116669778  [KO:K04427] [EC:2.7.11.25]
116670334  [KO:K05702]
116670487  lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
116670542  [KO:K05699]
116670594  [KO:K18269]
116670634  rock2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.39]
116670942  rac1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
116671011  [KO:K05627]
116671026  tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
116671068  [KO:K04498] [EC:2.3.1.48]
116671183  [KO:K05700]
116671234  [KO:K26418]
116671269  erbb2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
116671334  [KO:K12758]
116671389  [KO:K06592]
116671546  [KO:K07861]
116672026  [KO:K04237]
116672100  yes1; tyrosine-protein kinase Yes [KO:K05705] [EC:2.7.10.2]
116672244  [KO:K04674] [EC:2.7.11.30]
116672459  [KO:K12757]
116672557  wasf3; wiskott-Aldrich syndrome protein family member 3 [KO:K06083]
116672982  [KO:K23612]
116673739  nectin1; nectin-1 isoform X1 [KO:K06081]
116674205  nlk; serine/threonine-protein kinase NLK isoform X1 [KO:K04468] [EC:2.7.11.24]
116675778  actn4; alpha-actinin-4 isoform X1 [KO:K05699]
116675814  [KO:K05701]
116676313  [KO:K05689]
116679172  [KO:K05694] [EC:3.1.3.48]
116679407  [KO:K02620]
116679429  [KO:K05694] [EC:3.1.3.48]
116679482  [KO:K06083]
116679832  [KO:K05703] [EC:2.7.10.2]
116683564  [KO:K06086]
116684829  [KO:K05706]
116685754  [KO:K04490]
116685833  [KO:K20644]
116686075  [KO:K04490]
116686640  pdcd10; programmed cell death protein 10 [KO:K18269]
116686662  [KO:K10351]
116686679  iqgap1; ras GTPase-activating-like protein IQGAP1 [KO:K16848]
116686746  [KO:K04388] [EC:2.7.11.30]
116687052  [KO:K04362] [EC:2.7.10.1]
116687220  [KO:K03097] [EC:2.7.11.1]
116687400  [KO:K10351]
116687594  [KO:K05704] [EC:2.7.10.2]
116687703  [KO:K04513]
116687975  [KO:K03097] [EC:2.7.11.1]
116688064  [KO:K12755]
116688197  [KO:K05707]
116688259  [KO:K04513]
116688288  [KO:K04393]
116688344  [KO:K04353]
116688401  [KO:K23612]
116688903  smad4; mothers against decapentaplegic homolog 4 [KO:K04501]
116689310  [KO:K10351]
116689632  myl7; myosin regulatory light chain 2, atrial isoform isoform X1 [KO:K12754]
116689954  [KO:K05692]
116690322  mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
116690381  [KO:K04362] [EC:2.7.10.1]
116691055  [KO:K03097] [EC:2.7.11.1]
116691067  [KO:K03115]
116691157  [KO:K03097] [EC:2.7.11.1]
116691208  rasip1; ras-interacting protein 1 [KO:K26417]
116691237  ptpn6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
116691244  nectin2; nectin-2 isoform X1 [KO:K06531]
116691327  [KO:K04393]
116691343  ctnnb1; catenin beta-1 isoform X1 [KO:K02105]
116691511  [KO:K05627]
116691940  [KO:K04513]
116692018  [KO:K04513]
116692074  [KO:K05696] [EC:3.1.3.48]
116692093  [KO:K04353]
116692170  [KO:K04393]
116692349  [KO:K05707]
116692383  was; LOW QUALITY PROTEIN: wiskott-Aldrich syndrome protein [KO:K05747]
116692455  [KO:K04513]
116692732  [KO:K05704] [EC:2.7.10.2]
116693711  met; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
116693736  [KO:K23612]
116693851  [KO:K05701]
116693999  [KO:K05698] [EC:3.1.3.48]
116694001  smad3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
116694009  [KO:K05087] [EC:2.7.10.1]
116694198  [KO:K03097] [EC:2.7.11.1]
116694456  [KO:K06084]
116694654  [KO:K05087] [EC:2.7.10.1]
116695046  farp2; FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X1 [KO:K06082]
116695494  ptprf; receptor-type tyrosine-protein phosphatase F [KO:K05695] [EC:3.1.3.48]
116695719  [KO:K05690]
116695979  ssx2ip; afadin- and alpha-actinin-binding protein isoform X1 [KO:K06085]
116695992  [KO:K04527] [EC:2.7.10.1]
116696318  ctnnd1; catenin delta-1 isoform X1 [KO:K05690]
116696602  [KO:K05689]
116696719  [KO:K26418]
116697359  ctnna1; catenin alpha-1 [KO:K05691]
116698006  heg1; protein HEG homolog 1 isoform X1 [KO:K24472]
116698291  [KO:K06081]
116698307  lmo7; LIM domain only protein 7 isoform X1 [KO:K06084]
116698538  [KO:K12757]
116698561  snai2; LOW QUALITY PROTEIN: zinc finger protein SNAI2 [KO:K05706]
116698610  rock1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.39]
116698703  [KO:K04527] [EC:2.7.10.1]
116698815  egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
116698817  [KO:K20644]
116698987  ctnna2; catenin alpha-2 [KO:K05691]
116699109  ptprm; receptor-type tyrosine-protein phosphatase mu isoform X1 [KO:K05693] [EC:3.1.3.48]
116699402  [KO:K06593]
116699792  [KO:K04237]
116699800  [KO:K05705] [EC:2.7.10.2]
116699807  [KO:K06085]
116699847  [KO:K05695] [EC:3.1.3.48]
116700019  [KO:K06081]
116700034  smurf2; E3 ubiquitin-protein ligase SMURF2 [KO:K04678] [EC:2.3.2.26]
116700057  [KO:K06083]
116700180  tcf7; transcription factor 7 isoform X1 [KO:K02620]
116700724  [KO:K06592]
116701310  [KO:K02105]
116701576  wasf2; LOW QUALITY PROTEIN: wiskott-Aldrich syndrome protein family member 2 [KO:K05748]
116701648  krit1; krev interaction trapped protein 1 [KO:K17705]
116701720  [KO:K04388] [EC:2.7.11.30]
116701733  [KO:K05692]
116701833  [KO:K04393]
116702024  [KO:K03115]
116702155  [KO:K04501]
116702356  [KO:K05627]
116702370  [KO:K04678] [EC:2.3.2.26]
116702491  [KO:K04392]
116702633  crebbp; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
116702688  [KO:K26418]
116702788  [KO:K04498] [EC:2.3.1.48]
116702998  [KO:K04468] [EC:2.7.11.24]
116703057  [KO:K04678] [EC:2.3.2.26]
116703193  actb; actin, cytoplasmic 1 [KO:K05692]
116703217  mylpf; myosin regulatory light chain 2, skeletal muscle isoform [KO:K12758]
116703520  [KO:K06085]
116703753  [KO:K04371] [EC:2.7.11.24]
116704114  [KO:K04501]
116704504  [KO:K07860]
116704516  [KO:K23605]
116704619  [KO:K07861]
116705377  [KO:K05700]
116705586  [KO:K06533]
116705871  [KO:K17388] [EC:2.7.11.39]
116705947  fyn; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
116706015  wasf1; wiskott-Aldrich syndrome protein family member 1 isoform X1 [KO:K05753]
116706210  map3k7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
116706300  afdn; LOW QUALITY PROTEIN: afadin [KO:K05702]
116706371  ccm2; cerebral cavernous malformations 2 protein isoform X1 [KO:K26416]
116706389  acp1; low molecular weight phosphotyrosine protein phosphatase isoform X1 [KO:K14394] [EC:3.1.3.2 3.1.3.48]
116706615  [KO:K04498] [EC:2.3.1.48]
116707058  [KO:K06593]
116707113  [KO:K06083]
116707440  [KO:K06593]
Reference
  Authors
Nelson WJ, Nusse R.
  Title
Convergence of Wnt, beta-catenin, and cadherin pathways.
  Journal
Science 303:1483-7 (2004)
DOI:10.1126/science.1094291
Reference
  Authors
Potter E, Bergwitz C, Brabant G.
  Title
The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.
  Journal
Endocr Rev 20:207-39 (1999)
DOI:10.1210/edrv.20.2.0362
Reference
  Authors
Beavon IR.
  Title
The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.
  Journal
Eur J Cancer 36:1607-20 (2000)
DOI:10.1016/S0959-8049(00)00158-1
Reference
  Authors
Reynolds AB, Roczniak-Ferguson A.
  Title
Emerging roles for p120-catenin in cell adhesion and cancer.
  Journal
Oncogene 23:7947-56 (2004)
DOI:10.1038/sj.onc.1208161
Reference
  Authors
Angst BD, Marcozzi C, Magee AI.
  Title
The cadherin superfamily: diversity in form and function.
  Journal
J Cell Sci 114:629-41 (2001)
Reference
  Authors
Lilien J, Balsamo J, Arregui C, Xu G.
  Title
Turn-off, drop-out: functional state switching of cadherins.
  Journal
Dev Dyn 224:18-29 (2002)
DOI:10.1002/dvdy.10087
Reference
  Authors
Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M.
  Title
p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.
  Journal
Mol Cell Biol 23:2287-97 (2003)
DOI:10.1128/MCB.23.7.2287-2297.2003
Reference
  Authors
Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A.
  Title
Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.
  Journal
J Cell Biol 163:847-57 (2003)
DOI:10.1083/jcb.200308162
Reference
  Authors
Ciruna B, Rossant J.
  Title
FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak.
  Journal
Dev Cell 1:37-49 (2001)
DOI:10.1016/S1534-5807(01)00017-X
Reference
  Authors
Peinado H, Quintanilla M, Cano A.
  Title
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.
  Journal
J Biol Chem 278:21113-23 (2003)
DOI:10.1074/jbc.M211304200
Reference
  Authors
Labbe E, Letamendia A, Attisano L.
  Title
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
  Journal
Proc Natl Acad Sci U S A 97:8358-63 (2000)
DOI:10.1073/pnas.150152697
Reference
  Authors
Nakanishi H, Takai Y.
  Title
Roles of nectins in cell adhesion, migration and polarization.
  Journal
Biol Chem 385:885-92 (2004)
DOI:10.1515/BC.2004.116
Reference
  Authors
Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.
  Title
Roles and modes of action of nectins in cell-cell adhesion.
  Journal
Semin Cell Dev Biol 15:643-56 (2004)
DOI:10.1016/j.semcdb.2004.09.002
Related
pathway
esp04010  MAPK signaling pathway
esp04060  Cytokine-cytokine receptor interaction
esp04310  Wnt signaling pathway
esp04350  TGF-beta signaling pathway
esp04530  Tight junction
esp04810  Regulation of actin cytoskeleton
KO pathway
ko04520   

DBGET integrated database retrieval system